Condensed Consolidated Statements of Cash Flows - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
CASH PROVIDED BY/(USED IN) OPERATING ACTIVITIES
Net earnings	$ 760	$ 920
Adjustments to reconcile net earnings to operating cash flows:
Depreciation and amortization	256	258
Stock-based compensation expense	28	32
Deferred income tax provision/(benefit)	(26)	2
Asset impairments and accelerated depreciation	0	5
Gains on equity method investment transactions	(71)	(23)
Equity method investment net earnings	(138)	(113)
Distributions from equity method investments	165	160
Other non-cash items, net	126	16
Change in assets and liabilities, net of acquisitions and divestitures:
Receivables, net	(610)	(570)
Inventories, net	(48)	(36)
Accounts payable	206	(139)
Other current assets	(217)	47
Other current liabilities	(71)	(45)
Change in pension and postretirement assets and liabilities, net	(76)	(49)
Net cash provided by operating activities	284	465
CASH PROVIDED BY/(USED IN) INVESTING ACTIVITIES
Capital expenditures	(214)	(265)
Proceeds from divestitures including equity method investments	185	0
Other	(26)	42
Net cash used in investing activities	(55)	(223)
CASH PROVIDED BY/(USED IN) FINANCING ACTIVITIES
Issuances of commercial paper, maturities greater than 90 days	157	610
Repayments of commercial paper, maturities greater than 90 days	(497)	(1,549)
Net issuances of other short-term borrowings	2,477	1,815
Long-term debt proceeds	0	597
Long-term debt repaid	(670)	(403)
Repurchase of Common Stock	(720)	(646)
Dividends paid	(409)	(380)
Other	117	157
Net cash provided by financing activities	455	201
Effect of exchange rate changes on cash, cash equivalents and restricted cash	(60)	(1)
Cash, cash equivalents and restricted cash:
Increase	624	442
Balance at beginning of period	1,328	1,100
Balance at end of period	$ 1,952	$ 1,542